Written answers

Thursday, 3 April 2014

Department of Health

Primary Care Reimbursement Service Payments

Photo of Aengus Ó SnodaighAengus Ó Snodaigh (Dublin South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

244. To ask the Minister for Health if consideration has been given to making the new drug in the treatment of hepatitis C, Telebiron or Vivtielis available to sufferers in the State; and if he will make a statement on the matter. [15774/14]

Photo of Aengus Ó SnodaighAengus Ó Snodaigh (Dublin South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

256. To ask the Minister for Health the reason the drugs Telebiron and Vivtielis are not available to hepatitis C sufferers; and if there are plans to make these drugs available in the future. [15858/14]

Photo of Alex WhiteAlex White (Dublin South, Labour)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 244 and 256 together.

It is assumed the Deputy is referring to Telaprevir (Incivo) and Victrelis (Boceprevir). These drugs are currently available via the Primary Care Reimbursement Service Hepatitis C Reimbursement System, when prescribed via the eight National designated Hepatitis C centres.

Comments

No comments

Log in or join to post a public comment.